DNAJC16 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.859800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.508000E-01
Normal-vs-Stage2
3.713400E-01
Normal-vs-Stage3
1.541830E-02
Normal-vs-Stage4
6.592600E-01
Stage1-vs-Stage2
8.948000E-01
Stage1-vs-Stage3
2.863600E-02
Stage1-vs-Stage4
2.620400E-01
Stage2-vs-Stage3
2.486200E-02
Stage2-vs-Stage4
3.290600E-01
Stage3-vs-Stage4
9.836100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.476600E-01
Normal-vs-AfricanAmerican
9.282800E-01
Normal-vs-Asian
6.154800E-01
Caucasian-vs-AfricanAmerican
2.595400E-01
Caucasian-vs-Asian
7.309400E-01
AfricanAmerican-vs-Asian
5.972600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.305800E-01
Normal-vs-Female
4.643200E-01
Male-vs-Female
6.480600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.612600E-01
Normal-vs-Age(41-60Yrs)
7.561800E-01
Normal-vs-Age(61-80Yrs)
2.925400E-01
Normal-vs-Age(81-100Yrs)
1.154410E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.252200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.922800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.073800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.675300E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.079900E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.142600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.495170E-01
Normal-vs-Daily Drinker
1.913400E-01
Normal-vs-Weekly Drinker
1.763440E-01
Normal-vs-Occasional Drinker
9.076200E-01
Normal-vs-Social Drinker
5.245800E-01
Non Drinker-vs-Daily Drinker
6.211200E-01
Non Drinker-vs-Weekly Drinker
9.070600E-01
Non Drinker-vs-Occasional Drinker
2.740500E-02
Non Drinker-vs-Social Drinker
9.565700E-02
Daily Drinker-vs-Weekly Drinker
7.604000E-01
Daily Drinker-vs-Occasional Drinker
7.943600E-02
Daily Drinker-vs-Social Drinker
2.095600E-01
Weekly Drinker-vs-Occasional Drinker
9.137700E-02
Weekly Drinker-vs-Social Drinker
1.689230E-01
Occasional Drinker-vs-Social Drinker
5.228600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.444830E-01
Normal-vs-Grade 2
5.641700E-02
Normal-vs-Grade 3
3.099500E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.538800E-01
Grade 1-vs-Grade 3
9.051200E-01
Grade 1-vs-Grade 4
1.444830E-01
Grade 2-vs-Grade 3
6.821600E-01
Grade 2-vs-Grade 4
5.641700E-02
Grade 3-vs-Grade 4
3.099500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.817820E-01
Normal-vs-NonDiabetic
3.175400E-01
Diabetic-vs-NonDiabetic
2.362000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.165620E-01
Normal-vs-NoPancreatitis
3.282600E-01
Pancreatitis-vs-NoPancreatitis
4.112600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.255200E-01
Normal-vs-N1
3.671000E-01
N0-vs-N1
9.161600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.568000E-01
Normal-vs-TP53-NonMutant
6.838200E-01
TP53-Mutant-vs-TP53-NonMutant
9.943400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
